Abstract

Various TRP channels act as polymodal sensors of thermal and chemical stimuli, but the mechanisms whereby chemical ligands impact on TRP channel gating are poorly understood. Here we show that AITC (allyl isothiocyanate; mustard oil) and menthol represent two distinct types of ligands at the mammalian cold sensor TRPM8. Kinetic analysis of channel gating revealed that AITC acts by destabilizing the closed channel, whereas menthol stabilizes the open channel, relative to the transition state. Based on these differences, we classify agonists as either type I (menthol-like) or type II (AITC-like), and provide a kinetic model that faithfully reproduces their differential effects. We further demonstrate that type I and type II agonists have a distinct impact on TRPM8 currents and TRPM8-mediated calcium signals in excitable cells. These findings provide a theoretical framework for understanding the differential actions of TRP channel ligands, with important ramifications for TRP channel structure-function analysis and pharmacology.

Article and author information

Author details

  1. Annelies Janssens

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  2. Maarten Gees

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  3. Balazs Istvan Toth

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  4. Debapriya Ghosh

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  5. Marie Mulier

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  6. Rudi Vennekens

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  7. Joris Vriens

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  8. Karel Talavera

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    Competing interests
    The authors declare that no competing interests exist.
  9. Thomas Voets

    Laboratory of Ion Channel Research, University of Leuven, Leuven, Belgium
    For correspondence
    thomas.voets@med.kuleuven.be
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5526-5821

Funding

Fonds Wetenschappelijk Onderzoek (G.0565.07)

  • Thomas Voets

Onderzoeksraad, KU Leuven (PF-TRPLe)

  • Rudi Vennekens
  • Thomas Voets

Belspo (IUAP P7/13)

  • Rudi Vennekens
  • Karel Talavera
  • Thomas Voets

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experiments were approved by the KU Leuven Ethical Committee Laboratory Animals under project number P192/2014.

Copyright

© 2016, Annelies et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,653
    views
  • 576
    downloads
  • 26
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Annelies Janssens
  2. Maarten Gees
  3. Balazs Istvan Toth
  4. Debapriya Ghosh
  5. Marie Mulier
  6. Rudi Vennekens
  7. Joris Vriens
  8. Karel Talavera
  9. Thomas Voets
(2016)
Definition of two agonist types at the mammalian cold-activated channel TRPM8
eLife 5:e17240.
https://doi.org/10.7554/eLife.17240

Share this article

https://doi.org/10.7554/eLife.17240

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Jie Luo, Jeff Ranish
    Tools and Resources

    Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.

    1. Structural Biology and Molecular Biophysics
    Yuanyuan Wang, Fan Xu ... Yongning He
    Research Article

    SCARF1 (scavenger receptor class F member 1, SREC-1 or SR-F1) is a type I transmembrane protein that recognizes multiple endogenous and exogenous ligands such as modified low-density lipoproteins (LDLs) and is important for maintaining homeostasis and immunity. But the structural information and the mechanisms of ligand recognition of SCARF1 are largely unavailable. Here, we solve the crystal structures of the N-terminal fragments of human SCARF1, which show that SCARF1 forms homodimers and its epidermal growth factor (EGF)-like domains adopt a long-curved conformation. Then, we examine the interactions of SCARF1 with lipoproteins and are able to identify a region on SCARF1 for recognizing modified LDLs. The mutagenesis data show that the positively charged residues in the region are crucial for the interaction of SCARF1 with modified LDLs, which is confirmed by making chimeric molecules of SCARF1 and SCARF2. In addition, teichoic acids, a cell wall polymer expressed on the surface of gram-positive bacteria, are able to inhibit the interactions of modified LDLs with SCARF1, suggesting the ligand binding sites of SCARF1 might be shared for some of its scavenging targets. Overall, these results provide mechanistic insights into SCARF1 and its interactions with the ligands, which are important for understanding its physiological roles in homeostasis and the related diseases.